Search clinical trials for: Blopress (Candesartan)

Total 195 results

Novartis

Completed

Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension (AMAZING)

Hypertension

Germany
Shin Poong Pharmaceutical Co. Ltd.

Completed

Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension (SP-CAP-002)

Hypertension | Essential Hypertension

Korea, Republic of
Seoul National University Hospital

Unknown

Comparison of Vascular Remodeling Between Different Antianginal Medication Evaluated by Noninvasive ECG-gated Fundus Photographic Evaluation

Stable Angina

Korea, Republic of
University of California, San Diego
Baxter Healthcare Corporation; Scripps Health; Home Dialysis Therapies of San...

Active, not recruiting

Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight (DREAM-APD)

Efficacy | Safety Issues

United States
Vanderbilt University

Completed

The RAS, Fibrinolysis and Cardiopulmonary Bypass

Coronary Artery Disease | Inflammation | Cardiopulmonary Bypass | Fibrinolysis | Angiotensin Receptor Blockers | Angiotensin Converting Enzyme

United States
Uppsala University

Completed

The Precision Hypertension Care Study (PHYSIC)

Hypertension

Sweden
Brigham and Women's Hospital

Active, not recruiting

Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

Frailty | Heart Failure, Systolic

United States
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011)

Hepatitis C
Umeå University
AstraZeneca; Sahlgrenska University Hospital, Sweden

Completed

Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

Hypertension | Obesity

Sweden
Xijing Hospital

Withdrawn

China Stroke Secondary Prevention Trial (CSSPT)

Stroke | Transient Ischemic Attack

China
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Genetic Epidemiology of Responses to Antihypertensives (GERA)

Heart Diseases | Cardiovascular Diseases | Hypertension

United States
Assistance Publique - Hôpitaux de Paris

Completed

Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker

Healthy

France
Baim Institute for Clinical Research
Beth Israel Deaconess Medical Center

Completed

Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions (CORAL)

Cardiovascular Diseases | Atherosclerosis | Renal Artery Obstruction | Hypertension, Renovascular

United States
Sherief Abd-Elsalam

Recruiting

Statins and ARBs on Rheumatoid Activity

Rheumatoid Arthritis

Egypt
Hospices Civils de Lyon

Completed

Efficacy of Prazosin in Preventing Post-traumatic Stress Disorder (PRAZOSTRESS)

Acute Stress Disorder

France
Alvogen Korea

Completed

Pharmacokinetic Drug Interaction Between Candesartan and Rosuvastatin

Healthy

Korea, Republic of
Baylor College of Medicine
National Institute on Drug Abuse (NIDA)

Completed

An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence

Substance Abuse | Methamphetamine Dependence | Methamphetamine Abuse

United States
Norwegian University of Science and Technology
AstraZeneca; St. Olavs Hospital; Kragerø Tablettproduksjon as, Norway

Completed

Candesartan Versus Propranolol for Migraine Prevention

Chronic Migraine | Migraine Without Aura | Migraine With Aura

Norway
Western Regional Medical Center

Terminated

Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer (PembroMab)

Breast Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Advanced Cancer

United States
HanAll BioPharma Co., Ltd.

Completed

Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg

Hypertension

Korea, Republic of
University of Pavia

Unknown

Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension

Essential Hypertension

Italy
Vanderbilt University

Terminated

Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression

Depression | Hypertension

United States
Emory University
National Institute on Aging (NIA)

Completed

CAndesartan vs LIsinopril Effects on the BRain (CALIBREX)

Hypertension | Mild Cognitive Impairment

United States
University of Siena

Completed

Prescription-grade Crystalline Glucosamine Sulfate Therapy in Erosive Hand Osteoarthritis

Erosive Osteoarthritis of the Hand

Italy
Medical University of Vienna
Medical University of Graz; Medical University Innsbruck; SMZ-Ost Donauspital; Hospital... and other collaborators

Unknown

Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) (ACOVACT)

COVID-19

Austria
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Terminated

Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection? (ARBs CORONA II)

Covid19 | SARS-CoV Infection

Canada, France
The George Institute

Completed

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease (CLARITY)

COVID-19 | Coronavirus Disease 2019

Australia, India
US Department of Veterans Affairs
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)

Osteoarthritis

United States
University of Southern California
National Institute on Aging (NIA); Hebrew SeniorLife

Completed

The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial (AVEC)

Hypertension | Cognitive Impairment | Aging

United States
Danish Headache Center

Recruiting

Post-traumatic Headache Multidisciplinary Study (PTHMS)

Post-Concussion Syndrome | Post-Traumatic Headache

Denmark
Kinnov Therapeutics
ECSOR

Completed

Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects (COCKTAIL)

Alcohol Use Disorder

France
University Hospital, Akershus
University of Oslo; AstraZeneca; Norwegian Cancer Society

Completed

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA)

Heart Failure | Breast Cancer

Norway
AstraZeneca

Recruiting

Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) (SERENA-6)

ER-Positive HER2-Negative Breast Cancer

United States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
Janssen R&D Ireland

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.

Healthy

United States
Janssen Research & Development, LLC

Completed

A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult Participants

Healthy

Belgium
University of Vigo
Servicio Gallego de Salud

Completed

Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment (HYGIA)

Stroke | Cardiovascular Disease | Chronic Kidney Disease | Essential Hypertension

Spain
AbbVie (prior sponsor, Abbott)
Abbott Japan Co.,Ltd

Completed

Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease

Advanced Parkinson's Disease
Vitality in Aging Research Group, Inc.

Withdrawn

VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements

Aging
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaborators

Completed

Action to Control Cardiovascular Risk in Diabetes (ACCORD) (ACCORD)

Cardiovascular Diseases | Coronary Disease | Hypertension | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Atherosclerosis | Hypercholesterolemia

United States, Canada
Washington University School of Medicine
Assertio Holdings, Inc

Not yet recruiting

Intranasal Ketorolac Trial

Headache, Migraine
National University of Ireland, Galway, Ireland

Suspended

Coronavirus (COVID-19) ACEi/ARB Investigation (CORONACION)

COVID-19 | Hypertension

Ireland
Martin Huelsmann

Recruiting

NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

Heart Diseases | Diabetes Mellitus, Type 2

New Zealand, Austria, Netherlands, Spain, United Kingdom
University of Utah
Boston University; University of Pennsylvania; Northwestern University; Columbia... and other collaborators

Completed

ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

Hypertension | COVID

United States
AstraZeneca

Completed

Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

Heart Failure | Ventricular Dysfunction, Left

Sweden
UMC Utrecht
National University Hospital, Singapore; Berry Consultants; University of Pittsburgh... and other collaborators

Recruiting

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia (REMAP-CAP)

Community-acquired Pneumonia, Influenza, COVID-19

United Kingdom, United States, Canada, Australia, Netherlands, Croatia, Germany, Belgium, New Zealand, Ireland, Spain, Japan, Hungary, Colombia, India, Nepal, Pakistan, Portugal, Romania, Saudi Arabia

Search clinical trials for: Blopress (Candesartan)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations